Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional)
Key Information
Due Date: November 16, 2024
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant
Match Required: No
Contact Info:
OERWebmaster03@od.nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
This grant, classified as R03, is named "Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns," and it encourages research related to creating new ways of screening and/or treating serious or disabling conditions that can be identified in newborns. This includes conditions deemed as "high priority", which refers to genetic conditions that may be possible to screen in the near future. To qualify for this grant, it's necessary to have a precise screening test and showcase the advantages of early treatment or intervention. It's worth noting that a "high priority" condition is defined as one that's not currently recommended for screening. However, early identification and treatment would considerably benefit infants with that particular condition.
Show More
Key Dates
Open Date: November 9, 2021
Application Due Date: November 16, 2024
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses